(S)-4-BENZYL-2-(ISOQUINOLIN-1-YL)-4,5-DIHYDROOXAZOLE, 95%, 1g

Tert-butyl (R)-3-aminobutanoate, 95+%, 100mg

3-Ethylbicyclo[3.2.0]hept-3-en-6-one, 95%, 5g

ethyl 2,6-dichloro-3-methylpyridine-4-carboxylate, 97.0%, 250mg

1-(pyridine-3-carbonyl)-1,4-diazepane, 95.0%, 1g

3-Bromo-2-fluoropyridine, 98.0%, 5g

((5-Bromo-2-chlorobenzyl)oxy)(tert-butyl)dimethylsilane, 98%, 5g

4-(5-methyl-1H-pyrazol-3-yl)pyridine, 95.0%, 250mg

Sodium hydroxide, min. 98%, pa, ISO, in pellets, 500 g, plastic packaging.

(((9H-fluoren-9-yl)methoxy)carbonyl)-L-serine hydrate, 98%, 25g

1-(4-Hydroxyphenyl)propan-2-one, 98.0%, 25g

Ethylhydrazine oxalate, 95.0%, 5g

1-Phenyl-3-(2,4,6-trimethylphenyl)-2-pyrazoline>98.0%(GC)1g